These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 21752528)

  • 1. Conservative management of a haemorrhagic adnexal cyst in a patient with Type 3 von Willebrand Disease.
    Boama V; Haynes S
    Eur J Obstet Gynecol Reprod Biol; 2011 Nov; 159(1):236-7. PubMed ID: 21752528
    [No Abstract]   [Full Text] [Related]  

  • 2. Management of delivery with FVIII/VWF concentrates in a pregnant woman with type 3 von Willebrand disease and alloantibodies.
    Martín-Salces M; Jiménez-Yuste V; Álvarez-Román MT; Rivas-Pollmar I; Rodríguez de la Rúa A
    Thromb Haemost; 2012 Oct; 108(4):796-8. PubMed ID: 22836221
    [No Abstract]   [Full Text] [Related]  

  • 3. Haemorrhagic rupture of hepatic simple cysts.
    Simon T; Bakker IS; Penninga L; Nellensteijn DR
    BMJ Case Rep; 2015 Feb; 2015():. PubMed ID: 25697302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful use of tranexamic acid in the management of haemophilic pseudotumour.
    Sagheer S; Atkins A; McRae S
    Haemophilia; 2016 Jul; 22(4):e306-9. PubMed ID: 27291716
    [No Abstract]   [Full Text] [Related]  

  • 5. [Von Willebrand disease--from biochemistry to clinical practice].
    Sveinsdottir SV; Hillarp A; Astermark J; Svensson PJ; Berntorp E
    Lakartidningen; 2010 Aug 25-31; 107(34):1923-7. PubMed ID: 20960954
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical use of Haemate-P in inherited von Willebrand's disease: a patient with type 3 VWD and recurrent menometrorrhagia.
    Dolatkhah R; Kermani IA; Sanaat Z; Seifi S; Ziaei JE; Nikanfar A; Esfehani A; Chavoushi SH
    Haemophilia; 2010 May; 16(3):555-7. PubMed ID: 20059558
    [No Abstract]   [Full Text] [Related]  

  • 7. Monitoring of coagulation factor therapy in patients with von Willebrand disease type 3 using a microchip flow chamber system.
    Ågren A; Holmström M; Schmidt DE; Hosokawa K; Blombäck M; Hjemdahl P
    Thromb Haemost; 2017 Jan; 117(1):75-85. PubMed ID: 27761577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Willebrand disease].
    Lequièvre V
    Rev Infirm; 2006; (122):22-4. PubMed ID: 16881452
    [No Abstract]   [Full Text] [Related]  

  • 9. Prophylaxis in von Willebrand Disease: Coming of Age?
    Saccullo G; Makris M
    Semin Thromb Hemost; 2016 Jul; 42(5):498-506. PubMed ID: 27253087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of Tranexamic Acid for the Treatment of Mittelschmerz in a Patient with Type 1 von Willebrand Disease and Recurrent Hemorrhagic Cysts.
    Lasry A; Gil Y; Balayla J
    J Obstet Gynaecol Can; 2020 Nov; 42(11):1385-1387. PubMed ID: 32482469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Practical aspects of factor concentrate use in patients with von Willebrand disease undergoing invasive procedures: a European survey.
    Windyga J; Dolan G; Altisent C; Katsarou O; López Fernández MF; Zülfikar B;
    Haemophilia; 2016 Sep; 22(5):739-51. PubMed ID: 27292438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous immunoglobulin treatment in a type 3 von Willebrand disease patient with alloantibodies and a life-threatening gastrointestinal bleed.
    Nummi V; Lehtinen E; Mäkipernaa A; Szanto T; Lassila R
    Haemophilia; 2019 Jul; 25(4):e291-e293. PubMed ID: 31050121
    [No Abstract]   [Full Text] [Related]  

  • 13. Giant abdominopelvic haematoma arising from ovulation in a Glanzmann's thrombasthenia patient with platelet refractoriness: treatment with surgery and intra-abdominal tranexamic acid.
    Buyukasik Y; Boyraz G; Selcuk I; Bektas O; Selcuk Tuncer Z
    Acta Haematol; 2012; 128(3):154-7. PubMed ID: 22890234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis and management of von Willebrand disease: a developing country perspective.
    Nair SC; Viswabandya A; Srivastava A
    Semin Thromb Hemost; 2011 Jul; 37(5):587-94. PubMed ID: 22102204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activated prothrombin complex concentrate in combination with tranexamic acid: a single centre experience for the treatment of mucosal bleeding and dental extraction in haemophilia patients with inhibitors.
    Windyga J; Stefanska-Windyga E; Odnoczko E; Baran B; Czubak G
    Haemophilia; 2016 Sep; 22(5):e465-8. PubMed ID: 27457184
    [No Abstract]   [Full Text] [Related]  

  • 16. Baseline factor VIII plasma levels and age at first bleeding in patients with severe forms of von Willebrand disease.
    Siboni SM; Biguzzi E; Caiani V; Mistretta C; Bucciarelli P; Peyvandi F
    Haemophilia; 2016 Jul; 22(4):564-9. PubMed ID: 26843468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acquired von Willebrand syndrome with a type 2B phenotype: diagnostic and therapeutic dilemmas.
    Scepansky E; Othman M; Smith H
    Acta Haematol; 2014; 131(4):213-7. PubMed ID: 24296552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retrospective review of the management of elective surgery with desmopressin and clotting factor concentrates in patients with von Willebrand disease.
    Nitu-Whalley IC; Griffioen A; Harrington C; Lee CA
    Am J Hematol; 2001 Apr; 66(4):280-4. PubMed ID: 11279640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dysfunctional uterine bleeding.
    Farrell E
    Aust Fam Physician; 2004 Nov; 33(11):906-8. PubMed ID: 15584330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Massive haemoperitoneum due to spontaneous rupture of ovarian cyst in children. A report of 2 cases.
    Sarihan H; Unal M; Ozoran Y
    S Afr J Surg; 1996 Feb; 34(1):44-6. PubMed ID: 8629190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.